Literature DB >> 24492729

Comparison of the effects of single doses of elcatonin and pregabalin on oxaliplatin-induced cold and mechanical allodynia in rats.

Manahito Aoki1, Yuki Kurauchi, Asami Mori, Tsutomu Nakahara, Kenji Sakamoto, Kunio Ishii.   

Abstract

Oxaliplatin frequently causes peripheral neuropathy. Clinical studies have indicated that pregabalin ameliorates oxaliplatin-induced peripheral neuropathy. However, pregabalin frequently causes dizziness and somnolence. We previously reported that elcatonin, a synthetic analog of eel calcitonin, attenuated oxaliplatin-induced cold and mechanical allodynia in rats. The aim of the present study was to compare the anti-allodynic effects of elcatonin and pregabalin in the rats developing the oxaliplatin-induced neuropathy. Male Sprague-Dawley rats were treated with a single dose of oxaliplatin (6 mg/kg, intraperitoneally (i.p.)) to induce cold and mechanical allodynia. We assessed the effects of subcutaneous elcatonin (20 U/kg) and oral pregabalin (30 mg/kg) on cold and mechanical allodynia by cold stimulation (8°C) to the hind paw of the rats and the von Frey test, respectively. Elcatonin reversed the effects of oxaliplatin-induced cold and mechanical allodynia in rats for a longer time period than pregabalin does. These results suggested that elcatonin might be useful for the clinical treatment of oxaliplatin-induced neuropathy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24492729     DOI: 10.1248/bpb.b13-00735

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  10 in total

1.  Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model.

Authors:  Radica Stepanović-Petrović; Ana Micov; Maja Tomić; Uroš Pecikoza
Journal:  Psychopharmacology (Berl)       Date:  2017-03-22       Impact factor: 4.530

2.  Pharmacological comparison of a nonhuman primate and a rat model of oxaliplatin-induced neuropathic cold hypersensitivity.

Authors:  Yuka Shidahara; Shinya Ogawa; Mari Nakamura; Shingo Nemoto; Yuji Awaga; Miyuki Takashima; Aldric Hama; Akihisa Matsuda; Hiroyuki Takamatsu
Journal:  Pharmacol Res Perspect       Date:  2016-02-08

3.  Analgesic, antiallodynic, and anticonvulsant activity of novel hybrid molecules derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide in animal models of pain and epilepsy.

Authors:  Anna Rapacz; Krzysztof Kamiński; Jolanta Obniska; Paulina Koczurkiewicz; Elżbieta Pękala; Barbara Filipek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-02-10       Impact factor: 3.000

4.  Somatosensory predictors of response to pregabalin in painful chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled, crossover study.

Authors:  Alexander Hincker; Karen Frey; Lesley Rao; Nina Wagner-Johnston; Arbi Ben Abdallah; Benjamin Tan; Manik Amin; Tanya Wildes; Rajiv Shah; Pall Karlsson; Kristopher Bakos; Katarzyna Kosicka; Leonid Kagan; Simon Haroutounian
Journal:  Pain       Date:  2019-08       Impact factor: 7.926

5.  Wide-Range Measurement of Thermal Preference-A Novel Method for Detecting Analgesics Reducing Thermally-Evoked Pain in Mice.

Authors:  Kinga Sałat; Anna Furgała-Wojas; Michał Awtoniuk; Robert Sałat
Journal:  Molecules       Date:  2021-01-25       Impact factor: 4.411

6.  Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients.

Authors:  Mitsuru Sugimoto; Tadayuki Takagi; Rei Suzuki; Naoki Konno; Hiroyuki Asama; Yuki Sato; Hiroki Irie; Yoshinori Okubo; Jun Nakamura; Mika Takasumi; Minami Hashimoto; Tsunetaka Kato; Ryoichiro Kobashi; Takuto Hikichi; Hiromasa Ohira
Journal:  BMC Cancer       Date:  2021-12-09       Impact factor: 4.430

7.  Antinociceptive and Antiallodynic Activity of Some 3-(3-Methylthiophen-2-yl)pyrrolidine-2,5-dione Derivatives in Mouse Models of Tonic and Neuropathic Pain.

Authors:  Anna Dziubina; Anna Rapacz; Anna Czopek; Małgorzata Góra; Jolanta Obniska; Krzysztof Kamiński
Journal:  Int J Mol Sci       Date:  2022-04-06       Impact factor: 5.923

Review 8.  Drug treatment for chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer.

Authors:  Mitsuru Sugimoto; Tadayuki Takagi; Rei Suzuki; Naoki Konno; Hiroyuki Asama; Yuki Sato; Hiroki Irie; Yoshinori Okubo; Jun Nakamura; Mika Takasumi; Minami Hashimoto; Tsunetaka Kato; Ryoichiro Kobashi; Takuto Hikichi; Hiromasa Ohira
Journal:  Fukushima J Med Sci       Date:  2022-02-23

9.  Transient receptor potential ankyrin 1 that is induced in dorsal root ganglion neurons contributes to acute cold hypersensitivity after oxaliplatin administration.

Authors:  Ken Yamamoto; Noriko Chiba; Terumasa Chiba; Toshie Kambe; Kenji Abe; Kazuyoshi Kawakami; Iku Utsunomiya; Kyoji Taguchi
Journal:  Mol Pain       Date:  2015-11-13       Impact factor: 3.395

Review 10.  Review of the Role of the Brain in Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Maryam Omran; Elizabeth K Belcher; Nimish A Mohile; Shelli R Kesler; Michelle C Janelsins; Andrea G Hohmann; Ian R Kleckner
Journal:  Front Mol Biosci       Date:  2021-06-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.